At the transcriptomic level there were no changes in striatal AMPA receptor subunits (GRIA1, GRIA2, GRIA3, GRIA4) expression levels between medicated and non-medicated groups of patients with SCH (Healy et al., 1998). This evidence concerns the gene GRIA4 and spindle cell hemangioma.